Avoid common mistakes on your manuscript.
Retraction Note to: Arch Gynecol Obstet (2004) 269:125–129 https://doi.org/10.1007/s00404-002-0437-x
The Editor-in Chief has retracted this article because it has been published previously [1]. All authors agree with this retraction.
Reference
Parsanezhad ME, Alborzi S, Jahromi BN (2002) A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Int J Fertil Womens Med 47(6):272–277
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Parsanezhad, M.E., Alborzi, S. & Namavar Jahromi, B. Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Arch Gynecol Obstet 309, 729 (2024). https://doi.org/10.1007/s00404-023-07330-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-023-07330-z